Different methodologies, such as single-marker versus multi-marker MSI panels and varied IHC protocols, can affect the detection rates of Lynch syndrome, especially for subtler MSH6 and PMS2 mutations known for their heterogeneous expression. The gene discussed is MSH6; the disease is Lynch syndrome.